More about our sector?

this is your place

Bigfinite Closes Series B Financing with Atlantic Bridge and Honeywell Ventures to Drive Disruption in Manufacturing Analytics

SAN FRANCISCO, CA – (November 4, 2019) – Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, announced that it has closed $15 million in financing with Atlantic Bridge, Honeywell Ventures and Institut Català de Finances. The new funding will be used to support the market expansion of Bigfinite’s SaaS platform, an AI-powered solution that helps pharmaceutical and biotech companies discover new ways to optimize manufacturing processes, reduce quality issues, and enhance regulatory compliance.

“Atlantic Bridge has an extraordinary track record of investment into the next wave of computing including in artificial intelligence (AI), big data, and Industry 4.0 while Honeywell Ventures’ expertise in the Internet of Things, analytics, and advanced manufacturing make this an ideal investment partnership for Bigfinite,” said CEO and co-founder, Pep Gubau. “We are honored and look forward to partnering with these organizations to further scale Bigfinite’s footprint within the life science manufacturing industry.”

“It is well known that billions of dollars annually could be saved through manufacturing process improvements and that a tremendous amount of data is never used,” said Andrew Smyth, Investment Director at Atlantic Bridge. “Bigfinite’s practical use of AI to provide predictive models will save the industry millions in lost product and dramatic reduction of effort to ensure compliance and data integrity.”

“Manufacturers around the world, particularly those in highly regulated industries, are looking for new and innovative ways to use data to optimize their operations,” said Murray Grainger, managing director, Honeywell Ventures. “Honeywell is pleased to make a strategic investment in Bigfinite, whose innovative platform will allow for life sciences manufacturing to be conducted in a faster and more productive manner, while enhancing compliance.”

Existing investors including Uncork Capital, Crosslink Capital and La Famiglia all participated in this funding round, bringing the total funding to date to more than $23.5 million. 

About Bigfinite, Inc.
Bigfinite is a solutions provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and pharma 4.0 technologies focused on optimizing pharmaceutical and biotech companies. The Bigfinite analytics platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Bigfinite offers an intuitive way to gain meaningful operational intelligence with data by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity. Founded in 2014, the company is based in San Francisco, California and also has a European office in Barcelona, Spain.

About Atlantic Bridge
Atlantic Bridge is a Global Growth Equity Technology Firm with over €900 million of assets under management across seven Funds, investing in technology companies in Europe and the US. We have offices and staff based in Palo Alto, London, Dublin, Munich and Paris.

About Honeywell Ventures
Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help everything from aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

Crystal Black

Bigfinite Closes Series B Financing with Atlantic Bridge and Honeywell Ventures to Drive Disruption in Manufacturing Analytics

2019 Xavier University AI Summit Reflections – Two Industries Ready for Change

Now that the dust has settled from the Xavier University AI Summit and our team is back to business, we’ve had time to process some of the highlights and key takeaways from the exciting event.  In the past few years, there has been a significant increase in the implementation of digital technologies into various industries that subsequently impacted the way we live, travel, and do business.  From driverless cars to 24/7 customer support chatbots, innovation and technology continue to spiral upward and as we’ve entered the 4th industrial revolution, and healthcare + biopharma should be no exception.  The Xavier University AI Summit is a great event that brings together a range of relevant stakeholders with common focus on artificial intelligence (AI).

Bigfinite and NNE Partnership

Bigfinite and NNE announced a strategic partner program agreement to collaborate around accelerating digital transformation within manufacturing operations at the world's leading pharmaceutical and biotech manufacturers. 

Where are Pharma Companies in the Age of Artificial Intelligence?

They say good things come to those who wait; we say good things come to those who wait but only the things left by the visionaries before them.  The pharmaceutical industry has long been known to lag in the adoption of new technology due to strong regulations. Even though regulators have recently begun to open up to several new ‘big data’ or pharma 4.0 technologies - the question remains, if pharma companies are doing the same?  In 2016, the European Pharmacopoeia 9.0 in Chapter 5.21 announced that neural networks (NN) and support vector machines (SVM) are valid chemometric techniques for processing analytical data sets. 

Data Scientist 4.0 – Bridging the World of Manufacturing and Data

Since the announcement of the 4th Industrial Revolution in 2011, multitudes of emerging technologies have transpired around “Industry 4.0”. Technologies such as digital twins, Industrial Internet of Things (IIoT), and cyber-physical systems have come into the scene as core elements, providing the necessary ingredients for a paradigm shift in manufacturing. Technologies around predictive analytics and artificial intelligence are pioneering new approaches with many use cases including predictive maintenance, autonomous process optimization, and pattern recognition - used to identify potential failures in real-time. Because of this, data science is becoming an invaluable discipline for our industry in order to transform information into knowledge.

Making the Conversation Real – What To Expect From The AI Manufacturing Team At Xavier University

Our co-founder and R&D Director Toni Manzano is a team lead for Xavier University AI in Manufacturing Team where, with the help of FDA officials and industry professionals, they address how the power of AI can be used to optimize manufacturing operations in the life sciences industry.

Taking Smart Manufacturing “Back to The Future”

What does the future look like in a smart factory in the pharma or biotech industry? We believe a smart factory is a digitally transformed facility and operation that is reaping the benefits of increased productivity. In fact, some experts predict an order of magnitude productivity gain! It is this productivity gain we need to aim and think about when talking digital transformation, it is the vision and the clear long-term goal. And yes, it is super important because with a clear goal it is easier to prioritize which technology to try first and where or what to digitally transform first, in other words, the strategy.

AWS re:Invent 2018 is Here!  Are You Ready?

Bigfinite is excited to announce that we will be attending the 2018 AWS re:Invent!  For the past three years, we have attended the annual conference and every year this event has continued to gain tremendous growth and take the city by storm.

Cultural Resistance… Who are the Real Enablers?

Advanced analytics technologies in the pharmaceutical industry are accessible now more than ever and regulators have slowly become more accepting of these kinds of advances.  The introduction of machine learning, artificial intelligence, and big data technologies are disrupting our industry, and it’s time we change our mindset.

Gartner Selects Bigfinite as “2018 Cool Vendor for Life Sciences”

We are excited to share that Bigfinite was selected as a 2018 Gartner Cool Vendor for Life Sciences - the only company solely focused on GxP manufacturing intelligence and analytics!